TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Investing.com

Pfizer Q3 Results Signal Shift From Covid Windfall to Obesity-Driven Growth Path

Investing.com Logo Investing.com By Khasay Hashimov
Pfizer Q3 Results Signal Shift From Covid Windfall to Obesity-Driven Growth Path

Pfizer reported Q3 earnings beating analyst expectations, with declining Covid revenues and a strategic pivot towards obesity therapies. The company is focusing on growth through pipeline expansion and potential acquisitions in the weight-loss drug market.

Insights
PFE   neutral

Mixed performance with earnings beat but declining Covid revenues, strategic shift towards obesity therapies indicates potential future growth opportunities